Nucleus Genomics Announces $3.5M Seed Round For A Fresh Take On Genetic Tests
PRIVATEDec 15, 2021
Amount Raised
$3.5 Million
Round Type
Seed
New YorkOtherBiotechnologySoftwareHealth Care
Description
When COVID-19 closed down most of society in 2020, Kian Sadeghi, like many of his then-classmates at the University of Pennsylvania, found himself holed up in his bedroom. He prefers it that way.
Who to call at Nucleus Genomics, and when
A new round usually means Nucleus Genomics is about to hire and buy. The teams that reach out first get the meeting.
An alert the day Nucleus Genomics raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at Nucleus Genomics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Nucleus Genomics. With Fundz connected, it knows.
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
Nucleus Genomics
Location
New York, New York, United States
About
Nucleus is an advanced DNA health test that takes the guesswork out of healthcare, whether it’s knowing your risk for cancer or planning for a healthy family.
Genomic testing has always been fragmented— there are over 70,000 genetic tests on the market today, each analyzing different genes or markers. Our technology combines all these tests into one to analyze your risk for over 800 conditions with a single swab.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Nucleus Genomics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.